BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 23404342)

  • 1. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
    Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
    J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells.
    Huang S; Guo W; Tang Y; Ren D; Zou X; Peng X
    Oncol Rep; 2012 Nov; 28(5):1831-7. PubMed ID: 22948942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
    Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
    Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.
    Wang M; Ren D; Guo W; Huang S; Wang Z; Li Q; Du H; Song L; Peng X
    Int J Oncol; 2016 Feb; 48(2):595-606. PubMed ID: 26647992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
    Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
    Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer.
    Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W
    J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
    Nam EH; Lee Y; Park YK; Lee JW; Kim S
    Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
    Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D
    Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.